395 related articles for article (PubMed ID: 15691562)
1. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
Aung T; Chan YH; Chew PT;
Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562
[TBL] [Abstract][Full Text] [Related]
2. Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma.
Aung T; Lim MC; Chan YH; Rojanapongpun P; Chew PT;
Ophthalmology; 2005 Jan; 112(1):28-32. PubMed ID: 15629816
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.
Chew PT; Aung T; Aquino MV; Rojanapongpun P;
Ophthalmology; 2004 Mar; 111(3):427-34. PubMed ID: 15019314
[TBL] [Abstract][Full Text] [Related]
4. Acute primary angle closure: configuration of the drainage angle in the first year after laser peripheral iridotomy.
Lim LS; Aung T; Husain R; Wu YJ; Gazzard G; Seah SK
Ophthalmology; 2004 Aug; 111(8):1470-4. PubMed ID: 15288973
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
Aung T; Wong HT; Yip CC; Leong JY; Chan YH; Chew PT
Ophthalmology; 2000 Jun; 107(6):1178-83. PubMed ID: 10857840
[TBL] [Abstract][Full Text] [Related]
6. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
8. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
9. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
10. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.
How AC; Kumar RS; Chen YM; Su DH; Gao H; Oen FT; Ho CL; Seah SK; Aung T
Br J Ophthalmol; 2009 Jun; 93(6):782-6. PubMed ID: 19336424
[TBL] [Abstract][Full Text] [Related]
11. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E;
Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
[TBL] [Abstract][Full Text] [Related]
12. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
Diestelhorst M; Larsson LI;
Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2006 Dec; 22(6):449-54. PubMed ID: 17238812
[TBL] [Abstract][Full Text] [Related]
15. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
[TBL] [Abstract][Full Text] [Related]
16. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study.
Kook MS; Cho HS; Yang SJ; Kim S; Chung J
J Ocul Pharmacol Ther; 2005 Feb; 21(1):75-84. PubMed ID: 15718831
[TBL] [Abstract][Full Text] [Related]
18. Diurnal intraocular pressure fluctuation and associated risk factors in eyes with angle closure.
Baskaran M; Kumar RS; Govindasamy CV; Htoon HM; Wong CY; Perera SA; Wong TT; Aung T
Ophthalmology; 2009 Dec; 116(12):2300-4. PubMed ID: 19850348
[TBL] [Abstract][Full Text] [Related]
19. Degree of angle closure and extent of peripheral anterior synechiae: an anterior segment OCT study.
Su DH; Friedman DS; See JL; Chew PT; Chan YH; Nolan WP; Smith SD; Huang D; Zheng C; Li Y; Foster PJ; Aung T
Br J Ophthalmol; 2008 Jan; 92(1):103-7. PubMed ID: 17584995
[TBL] [Abstract][Full Text] [Related]
20. Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
Konstas AG; Mylopoulos N; Karabatsas CH; Kozobolis VP; Diafas S; Papapanos P; Georgiadis N; Stewart WC
Eye (Lond); 2004 Sep; 18(9):893-9. PubMed ID: 15002024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
